- Home
- TSE vs ABOS Comparison
TSE vs ABOS Comparison
Compare TSE & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSE
- ABOS
- Stock Information
- Founded
- TSE 2010
- ABOS 1996
- Country
- TSE United States
- ABOS United States
- Employees
- TSE N/A
- ABOS N/A
- Industry
- TSE Major Chemicals
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- TSE Industrials
- ABOS Health Care
- Exchange
- TSE Nasdaq
- ABOS Nasdaq
- Market Cap
- TSE 112.7M
- ABOS 90.3M
- IPO Year
- TSE 2014
- ABOS 2021
- Fundamental
- Price
- TSE $2.96
- ABOS $1.57
- Analyst Decision
- TSE
- ABOS Strong Buy
- Analyst Count
- TSE 0
- ABOS 3
- Target Price
- TSE N/A
- ABOS $6.33
- AVG Volume (30 Days)
- TSE 560.1K
- ABOS 843.7K
- Earning Date
- TSE 08-06-2025
- ABOS 08-12-2025
- Dividend Yield
- TSE 1.35%
- ABOS N/A
- EPS Growth
- TSE N/A
- ABOS N/A
- EPS
- TSE N/A
- ABOS N/A
- Revenue
- TSE $3,394,000,000.00
- ABOS N/A
- Revenue This Year
- TSE $1.84
- ABOS N/A
- Revenue Next Year
- TSE $4.44
- ABOS N/A
- P/E Ratio
- TSE N/A
- ABOS N/A
- Revenue Growth
- TSE N/A
- ABOS N/A
- 52 Week Low
- TSE $2.16
- ABOS $0.86
- 52 Week High
- TSE $7.05
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- TSE 46.35
- ABOS 63.47
- Support Level
- TSE $2.78
- ABOS $1.54
- Resistance Level
- TSE $3.20
- ABOS $1.78
- Average True Range (ATR)
- TSE 0.16
- ABOS 0.12
- MACD
- TSE 0.01
- ABOS 0.02
- Stochastic Oscillator
- TSE 43.06
- ABOS 66.67
About TSE Trinseo PLC
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.